E191 ‘AI’s Impact on Global Pathology’ with Deciphex’s Donal O’Shea

Today's guest is Donal O'Shea, Chief Executive at Deciphex. Pathology is at the forefront of medical diagnostics, offering pivotal insights critical for patient treatment. Yet, in many parts of the world, there remains a stark shortage of pathologists, posing challenges to timely and accurate diagnoses. In this podcast, Donal shares his thrilling journey from academia to industry, where he has become a key player in utilising AI to enhance pathology services globally.Topics include:0:00 His journey from academia to corporate, pioneering digital pathology innovations5:03 How Pathology analyzes tissue samples to diagnose diseases and recommend treatments6:41 Why rising biopsy demand and fewer pathologists impact timely diagnoses10:03 AI aiding pathologists by integrating data, improving diagnostics and efficiency14:13 Facing challenges with data access, rarity and consent17:36 Why datasets in healthcare lack examples for certain endpoints, limiting synthesis19:18 Large AI models focus on high ROI applications, requiring specialized data21:12 The business focus on global scale, with a strong international network23:54 Focus on team-building, continuous growth and global commercialisation27:48 Improving global healthcare, reducing diagnostic wait times with AI

There are no comments yet.

Please log in to write the first comment.